{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:12:10Z","timestamp":1778829130506,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":40,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2022828"],"award-info":[{"award-number":["BE2022828"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["2023ZD0509000"],"award-info":[{"award-number":["2023ZD0509000"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1305700"],"award-info":[{"award-number":["2016YFC1305700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"},{"name":"Noncommunicable Chronic Diseases - National Science and Technology Major Project"},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.dsx.2025.103251","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:18:01Z","timestamp":1749237481000},"page":"103251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prediction of retinopathy risk: A prospective cohort study in China"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0950-9615","authenticated-orcid":false,"given":"Xiaohan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duolao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uazman","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanhu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zilin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2305-3749","authenticated-orcid":false,"given":"Anupam","family":"Garrib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.dsx.2025.103251_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13167-023-00314-8","article-title":"Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications\u2014risks and mitigation","volume":"14","author":"Kropp","year":"2023","journal-title":"EPMA J"},{"issue":"11","key":"10.1016\/j.dsx.2025.103251_bib2","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"48","key":"10.1016\/j.dsx.2025.103251_bib3","first-page":"3846","article-title":"A meta-analysis of prevalence of diabetic retinopathy in China","volume":"100","author":"Deng","year":"2020","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"3","key":"10.1016\/j.dsx.2025.103251_bib4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.dsx.2025.103251_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/antiox9100905","article-title":"Diabetic retinopathy: the role of mitochondria in the neural retina and microvascular disease","volume":"9","author":"Miller","year":"2020","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.dsx.2025.103251_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/ceo.12696","article-title":"Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review","volume":"44","author":"Ting","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.dsx.2025.103251_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanwpc.2022.100435","article-title":"Cost-effectiveness and cost-utility of traditional and telemedicine combined population-based age-related macular degeneration and diabetic retinopathy screening in rural and urban China","volume":"23","author":"Li","year":"2022","journal-title":"The Lancet Regional Health\u2013Western Pacific"},{"issue":"1","key":"10.1016\/j.dsx.2025.103251_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002374","article-title":"Social determinants of health impacting adherence to diabetic retinopathy examinations","volume":"9","author":"Cai","year":"2021","journal-title":"BMJ Open Diabetes Research and Care"},{"issue":"8","key":"10.1016\/j.dsx.2025.103251_bib9","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.dsx.2025.103251_bib10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ins.2007.07.020","article-title":"Ng EYK: identification of different stages of diabetic retinopathy using retinal optical images","volume":"178","author":"Yun","year":"2008","journal-title":"Inf Sci"},{"issue":"6","key":"10.1016\/j.dsx.2025.103251_bib11","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/dc12-0790","article-title":"Predicting development of proliferative diabetic retinopathy","volume":"36","author":"Harris","year":"2013","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.dsx.2025.103251_bib12","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.3390\/jcm11102761","article-title":"The effect of hyperlipidemia on the course of diabetic retinopathy\u2014literature review","volume":"11","author":"Bryl","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.dsx.2025.103251_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/dc18-2308","article-title":"Risk factors for retinopathy in type 1 diabetes: the DCCT\/EDIC study","volume":"42","author":"Hainsworth","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.dsx.2025.103251_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/jdi.12953","article-title":"Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus","volume":"10","author":"Song","year":"2019","journal-title":"Journal of diabetes investigation"},{"key":"10.1016\/j.dsx.2025.103251_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ebiom.2018.08.009","article-title":"Non-lab and semi-lab algorithms for screening undiagnosed diabetes: a cross-sectional study","volume":"35","author":"Li","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.dsx.2025.103251_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3343\/alm.2020.40.6.457","article-title":"Exploration and validation of the performance of hemoglobin A1c in detecting diabetes in community-dwellers with hypertension","volume":"40","author":"Qiu","year":"2020","journal-title":"Annals of Laboratory Medicine"},{"key":"10.1016\/j.dsx.2025.103251_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111761","article-title":"Can the postload-fasting glucose gap be used to determine risk of developing diabetes in Chinese adults: a prospective cohort study","volume":"213","author":"Xu","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.dsx.2025.103251_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.oret.2020.08.004","article-title":"Effect of ICD-9 to ICD-10 transition on accuracy of codes for stage of diabetic retinopathy and related complications: results from the CODER study","volume":"5","author":"Cai","year":"2021","journal-title":"Ophthalmology Retina"},{"key":"10.1016\/j.dsx.2025.103251_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1079217","article-title":"Classification of diabetic retinopathy: past, present and future","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.dsx.2025.103251_bib20","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dsx.2025.103251_bib21","article-title":"Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)","author":"Zhu","year":"2021","journal-title":"Chinese J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2025.103251_bib22","article-title":"Fasting plasma glucose and 2-h postprandial plasma glucose characteristics in a large multi-ethnic Chinese population","author":"Xu","year":"2023","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/j.dsx.2025.103251_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12874-020-01080-1","article-title":"Accuracy of random-forest-based imputation of missing data in the presence of non-normality, non-linearity, and interaction","volume":"20","author":"Hong","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.dsx.2025.103251_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eswa.2019.05.028","article-title":"A comparison of random forest variable selection methods for classification prediction modeling","volume":"134","author":"Speiser","year":"2019","journal-title":"Expert Syst Appl"},{"issue":"3","key":"10.1016\/j.dsx.2025.103251_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1177\/0962280217734241","article-title":"Measurement error correction in the least absolute shrinkage and selection operator model when validation data are available","volume":"28","author":"Vasquez","year":"2019","journal-title":"Stat Methods Med Res"},{"issue":"9","key":"10.1016\/j.dsx.2025.103251_bib26","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.3390\/app10093211","article-title":"Hybrid-recursive feature elimination for efficient feature selection","volume":"10","author":"Jeon","year":"2020","journal-title":"Applied Sciences"},{"issue":"3","key":"10.1016\/j.dsx.2025.103251_bib27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4236\/ojs.2023.133020","article-title":"Dealing with multicollinearity in factor analysis: the problem, detections, and solutions","volume":"13","author":"Kyriazos","year":"2023","journal-title":"Open J Stat"},{"issue":"10","key":"10.1016\/j.dsx.2025.103251_bib28","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/dme.13908","article-title":"Incidence of sight\u2010threatening diabetic retinopathy in people with Type 2 diabetes mellitus and numbers needed to screen: a systematic review","volume":"36","author":"Groeneveld","year":"2019","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.dsx.2025.103251_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1464-5491.2007.02043.x","article-title":"The prevalence of retinopathy in impaired glucose tolerance and recent\u2010onset diabetes in the Diabetes Prevention Program","volume":"24","author":"Group","year":"2007","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.dsx.2025.103251_bib30","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.survophthal.2022.04.002","article-title":"The prevalence of retinopathy in prediabetes: a systematic review","volume":"67","author":"Kirthi","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"10.1016\/j.dsx.2025.103251_bib31","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41433-022-02335-5","article-title":"Perspectives of diabetic retinopathy\u2014challenges and opportunities","volume":"37","author":"Sivaprasad","year":"2023","journal-title":"Eye (Lond 1990)"},{"issue":"1","key":"10.1016\/j.dsx.2025.103251_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/ijerph19010439","article-title":"Neurovascular impairment and therapeutic strategies in diabetic retinopathy","volume":"19","author":"Oshitari","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"issue":"10","key":"10.1016\/j.dsx.2025.103251_bib33","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/s41433-021-01572-4","article-title":"Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities","volume":"35","author":"Das","year":"2021","journal-title":"Eye (Lond 1990)"},{"issue":"8","key":"10.1016\/j.dsx.2025.103251_bib34","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/diacare.25.8.1320","article-title":"Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study","volume":"25","author":"Van Leiden","year":"2002","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.dsx.2025.103251_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0161-6420(02)01931-0","article-title":"The prevalence and risk factors of retinal microvascular abnormalities in older persons: the Cardiovascular Health Study","volume":"110","author":"Wong","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.dsx.2025.103251_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16086","article-title":"Metabolic syndrome traits differentially and cumulatively influence micro\u2010and macrovascular disease risk in patients with MASLD","author":"Henney","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.dsx.2025.103251_bib37","first-page":"703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","year":"1998","journal-title":"BMJ Br Med J (Clin Res Ed)"},{"issue":"4","key":"10.1016\/j.dsx.2025.103251_bib38","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Group DEr: effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2014revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.dsx.2025.103251_bib39","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ophtha.2015.04.029","article-title":"Influence of glycosylated hemoglobin on the efficacy of ranibizumab for diabetic macular edema: a post hoc analysis of the RIDE\/RISE trials","volume":"122","author":"Bansal","year":"2015","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.dsx.2025.103251_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1479164117746023","article-title":"Impact of metabolic control on macular thickness in diabetic macular oedema","volume":"15","author":"Peng","year":"2018","journal-title":"Diabetes Vasc Dis Res"},{"issue":"8","key":"10.1016\/j.dsx.2025.103251_bib41","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/IAE.0000000000000117","article-title":"Risk factors for proliferative diabetic retinopathy in a Latino American population","volume":"34","author":"Nittala","year":"2014","journal-title":"Retina (Phila, Pa)"},{"issue":"9","key":"10.1016\/j.dsx.2025.103251_bib42","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","article-title":"Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: early Treatment Diabetic Retinopathy Study (ETDRS) Report 22","volume":"114","author":"Chew","year":"1996","journal-title":"Archives of ophthalmology"},{"issue":"4","key":"10.1016\/j.dsx.2025.103251_bib43","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00125-022-05655-z","article-title":"Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies","volume":"65","author":"Jenkins","year":"2022","journal-title":"Diabetologia (Berl)"},{"key":"10.1016\/j.dsx.2025.103251_bib44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11906-003-0085-y","article-title":"Cardiometabolic syndrome: pathophysiology and treatment","volume":"5","author":"Castro","year":"2003","journal-title":"Curr Hypertens Rep"},{"issue":"26","key":"10.1016\/j.dsx.2025.103251_bib45","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3748\/wjg.v13.i26.3540","article-title":"Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Qureshi","year":"2007","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.dsx.2025.103251_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153988","article-title":"Supervised lifestyle intervention for people with metabolic syndrome improves outcomes and reduces individual risk factors of metabolic syndrome: a systematic review and meta-analysis","volume":"101","author":"van Namen","year":"2019","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.dsx.2025.103251_bib47","article-title":"Prevalence of diabetic retinopathy in mainland China","author":"Liu","year":"2012","journal-title":"a meta-analysis"},{"issue":"1","key":"10.1016\/j.dsx.2025.103251_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12886-022-02710-6","article-title":"Nomogram model predicts the risk of visual impairment in diabetic retinopathy: a retrospective study","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.dsx.2025.103251_bib49","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41387-022-00216-0","article-title":"Interpretable machine learning-derived nomogram model for early detection of diabetic retinopathy in type 2 diabetes mellitus: a widely targeted metabolomics study","volume":"12","author":"Li","year":"2022","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.dsx.2025.103251_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1196335","article-title":"Establishment and validation of a prognostic nomogram for long-term low vision after diabetic vitrectomy","volume":"14","author":"Guo","year":"2023","journal-title":"Front Endocrinol"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402125000682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402125000682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:50:28Z","timestamp":1778827828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402125000682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1871402125000682"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2025.103251","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of retinopathy risk: A prospective cohort study in China","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2025.103251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103251"}}